Healthcare Sector
Market Tracker
Represents the strikes that had the highest premium of whale flow (on the ASK side) over the past 5 trading days.
Represents the strikes that had the highest premium of whale flow (on the BID side) over the past 5 trading days.
Total Open Interest of Calls & Puts across all strikes and expirations over the past 16 trading days.
| Expires | Type | Strike | OI | Change | Percent |
|---|---|---|---|---|---|
| 05/17/2024 | PUT | $7.50 | 315 | +315 | |
| 05/17/2024 | CALL | $15.00 | 729 | +182 | +33.27% |
| 04/19/2024 | CALL | $15.00 | 3,877 | +60 | +1.57% |
| 07/19/2024 | CALL | $17.50 | 1,366 | +37 | +2.78% |
| 05/17/2024 | PUT | $12.50 | 480 | +29 | +6.43% |
| 07/19/2024 | CALL | $15.00 | 1,320 | +23 | +1.77% |
| 05/17/2024 | CALL | $17.50 | 1,533 | -4 | -0.26% |
| 04/19/2024 | PUT | $15.00 | 1,020 | -15 | -1.45% |
| 04/19/2024 | CALL | $12.50 | 4,778 | -33 | -0.69% |
| 04/19/2024 | PUT | $12.50 | 2,206 | -41 | -1.82% |
| 04/19/2024 | CALL | $17.50 | 3,928 | -44 | -1.11% |
| 04/19/2024 | PUT | $17.50 | 30 | -176 | -85.44% |
Contracts with largest changes in open interest from the previous trading day to the current/most recent.
| Name | Pct Held | Shares | Total |
|---|---|---|---|
| SPDR (R) Ser Tr-SPDR� Kensho New Economies Composite ETF | 2.76% | 1.79M | 13.78M |
| Vanguard Total Stock Market Index Fund | 2.37% | 1.53M | 11.81M |
| iShares Russell 2000 ETF | 1.63% | 1.06M | 8.14M |
| Vanguard Extended Market Index Fund | 1.06% | 683.23k | 5.27M |
| Fidelity Small Cap Index Fund | 0.61% | 393.73k | 3.04M |
| Invesco ETF Tr II-Invesco DWA Small Cap Momentum ETF | 0.42% | 273.91k | 2.11M |
| Fidelity Extended Market Index Fund | 0.39% | 253.96k | 1.96M |
| iShares Russell 2000 Growth ETF | 0.35% | 227.62k | 1.75M |
| Russell Inv Co- Tax-Managed U.S. Mid & Small Cap Fund | 0.28% | 178.93k | 1.38M |
| iShares Russell 2000 Value ETF | 0.26% | 169.92k | 1.31M |
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
04/02 09:00 am
GlobeNewswire Inc.
Read moreThe Analyst Landscape: 5 Takes On Liquidia
04/01 02:00 pm
Benzinga
Read moreUpdate on Favorable Legal and Regulatory Outcomes Clearing Path for Potential FDA approval of YUTREPIA™ (treprostinil) inhalation powder
04/01 06:00 am
GlobeNewswire Inc.
Read moreUnveiling 6 Analyst Insights On Liquidia
03/13 05:00 pm
Benzinga
Read moreLiquidia Technologies, Inc. (LQDA) Reports Q4 Loss, Lags Revenue Estimates
03/13 07:10 am
Zacks Investment Research
Read moreLiquidia Corporation Reports Full Year 2023 Financial Results and Provides Corporate Update
03/13 06:00 am
GlobeNewswire Inc.
Read moreArcturus Therapeutics (ARCT) Reports Q4 Loss, Misses Revenue Estimates
03/07 06:10 pm
Zacks Investment Research
Read moreEarnings Preview: Pliant Therapeutics, Inc. (PLRX) Q4 Earnings Expected to Decline
03/07 11:00 am
Zacks Investment Research
Read moreLiquidia Corporation to Report Full Year 2023 Financial Results on Wednesday, March 13, 2024
03/06 07:30 am
GlobeNewswire Inc.
Read moreArbutus Biopharma (ABUS) Reports Q4 Loss, Misses Revenue Estimates
02/29 09:40 am
Zacks Investment Research
Read moreArvinas, Inc. (ARVN) Reports Q4 Loss, Misses Revenue Estimates
02/27 09:30 am
Zacks Investment Research
Read moreUnited Therapeutics (UTHR) Q4 Earnings & Sales Beat Estimates
02/22 01:22 pm
Zacks Investment Research
Read moreStrength Seen in AnaptysBio, Inc. (ANAB): Can Its 5.9% Jump Turn into More Strength?
02/19 06:54 am
Zacks Investment Research
Read moreThis United Therapeutics Analyst Is No Longer Bearish, Expects Mid-Decade $4B Revenue Run Rate
02/12 12:00 pm
Benzinga
Read moreLiquidia Corporation Announces Poster Presentation at the Pulmonary Vascular Research Institute 2024 Annual Congress
01/30 07:30 am
GlobeNewswire Inc.
Read moreWall Street Analysts Think Liquidia Technologies, Inc. (LQDA) Could Surge 71.41%: Read This Before Placing a Bet
01/29 10:55 am
Zacks Investment Research
Read moreLiquidia Corporation Provides Update on New Drug Application for YUTREPIA™ (treprostinil) inhalation powder
01/25 07:00 am
GlobeNewswire Inc.
Read moreLiquidia Corporation Announces Updates to Operations Leadership
01/19 07:30 am
GlobeNewswire Inc.
Read moreWall Street Analysts Believe Liquidia Technologies, Inc. (LQDA) Could Rally 29.94%: Here's is How to Trade
01/09 07:21 pm
Zacks Investment Research
Read moreWhat Makes Liquidia Technologies, Inc. (LQDA) a Strong Momentum Stock: Buy Now?
01/09 05:56 pm
Zacks Investment Research
Read moreLiquidia Corporation Files Response to United Therapeutics Lawsuit and Files Counterclaims
01/08 09:22 am
GlobeNewswire Inc.
Read moreDecoding 5 Analyst Evaluations For Liquidia
01/05 09:00 am
Benzinga
Read moreLiquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
01/05 07:45 am
GlobeNewswire Inc.
Read moreLiquidia Corporation Announces $100 Million in New Financings
01/04 10:10 am
GlobeNewswire Inc.
Read moreLiquidia Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
01/02 07:45 am
GlobeNewswire Inc.
Read moreB of A Securities Maintains Buy Rating for Liquidia: Here's What You Need To Know
12/21 01:00 pm
Benzinga
Read moreU.S. Federal Circuit Affirms Earlier PTAB Decision to Invalidate All Claims of United Therapeutics Patent No. 10,716,793 (‘793 Patent)
12/20 05:56 pm
GlobeNewswire Inc.
Read moreToro Posts Upbeat Results, Joins Clear Channel Outdoor, Marathon Digital And Other Big Stocks Moving Higher On Wednesday
12/20 11:10 am
Benzinga
Read moreLiquidia Announces Pricing of Public Offering of Common Stock
12/12 08:13 am
GlobeNewswire Inc.
Read moreLiquidia Corporation Reports Third Quarter 2023 Financial Results and Provides Corporate Update
11/07 07:30 am
GlobeNewswire Inc.
Read moreLiquidia Corporation to Report Third Quarter 2023 Financial Results on November 7, 2023
10/31 06:30 am
GlobeNewswire Inc.
Read moreFDA Accepts Submission to Add PH-ILD to YUTREPIA™ Label
09/25 04:09 pm
GlobeNewswire Inc.
Read moreUnited Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent Office
09/06 04:30 pm
GlobeNewswire Inc.
Read moreWhy Maxeon Solar Technologies Are Trading Lower By Around 32%? Here Are Other Stocks Moving In Friday's Mid-Day Session
08/11 01:47 pm
Benzinga
Read moreWhat 5 Analyst Ratings Have To Say About Liquidia
08/10 02:00 pm
Benzinga
Read moreLiquidia Technologies, Inc. (LQDA) Reports Q2 Loss, Tops Revenue Estimates
08/10 07:15 am
Zacks Investment Research
Read moreLiquidia Corporation Reports Second Quarter 2023 Financial Results and Provides Corporate Update
08/10 06:00 am
GlobeNewswire Inc.
Read moreAdma Biologics (ADMA) Reports Q2 Loss, Tops Revenue Estimates
08/09 06:40 pm
Zacks Investment Research
Read moreArcus Biosciences, Inc. (RCUS) Reports Q2 Loss, Misses Revenue Estimates
08/07 09:15 am
Zacks Investment Research
Read moreLiquidia Corporation to Report Second Quarter 2023 Financial Results on August 10, 2023
08/03 08:17 am
GlobeNewswire Inc.
Read moreModerna (MRNA) Reports Q2 Loss, Tops Revenue Estimates
08/03 08:15 am
Zacks Investment Research
Read moreLiquidia Submits Amendment to Add PH-ILD Indication to Tentatively Approved NDA for YUTREPIA™ (treprostinil) Inhalation Powder
07/27 06:00 am
GlobeNewswire Inc.
Read moreWhere Liquidia Stands With Analysts
07/25 10:00 am
Benzinga
Read moreU.S. Federal Circuit Affirms All District Court Rulings in Patent Litigation
07/24 01:46 pm
GlobeNewswire Inc.
Read more